COMBINATION DRUG THERAPY FOR THE TREATMENT OF SOLID TUMORS

摘要

The present invention relates to a pharmaceutical combination that comprises an IGF1R inhibitor and an mTOR inhibitor for the treatment of cancer in a subject; a pharmaceutical composition comprising such a combination; the use of such a combination for the preparation of medicament for the treatment of cancer; a kit comprising such a combination as a combined preparation for simultaneous, separate or sequential use; and a method of treating cancer in a subject, especially a human.

主权项

1. A method for treating cancer in a subject comprising administering to the subject a therapeutically effective amount of an IGF1R inhibitor, or a pharmaceutical composition thereof, in combination with an mTOR inhibitor, or a pharmaceutical composition thereof.